Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: A critical overview

Coronary Artery Disease

Volumn 9, Issue 6, 1998, Pages 339-343

  Gupta, Sandeep ^a   Camm, A John ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chlamydia pneumoniae; Chronic infection; Coronary heart disease

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; ROXITHROMYCIN;

ANIMAL MODEL; ANTIMICROBIAL THERAPY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LABORATORY TEST; META ANALYSIS; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; SMOKING;

EID: 0031733616     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809060-00004     Document Type: Article

References (40)

1. Hansson GK. Immune mechanisms in atherosclerosis. Atherosclerosis 1989; 9:567-568.
2. Azar RR, Waters DD. The inflammatory aetiology of unstable angina. Am Heart J 1996; 132:1101-1106.
3. Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993; 14 (suppl K):12-16.
4. Buja LM. Does atherosclerosis have a infectious etiology? Circulation 1996; 94:872-873.
5. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350:430-436.
6. Grayston JT, Wang SP, Campbell LA, Kuo C-C. Current knowledge on Chlamydia pneumoniae strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis 1989; 8:191-202.
7. Grayston JT, Campbell LA, Kuo C-C, Mordhurst CH, Saikku P, Thom DH, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161:618-625.
8. Saikku P, Leinonen M, Mattila K, Ekman M, Nieminen N, Makela P, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; ii:983-986.
9. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman M, Manninen M, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116:273-278.
10. Wang SP, Grayston JT. Microimmunofluorescence serology in Chlamydia trachomatis. In de la Maza LM (editor). The 1983 international symposium on medical virology. New York: Elsevier Science; 1984. pp. 87-118.
11. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease: coincidence, association or causation? BMJ 1997; 314:1778-1779.
12. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82:158-161.
13. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167:841-849.
14. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13:1501-1504.
15. Campbell LA, O'Brien E, Cappuccio A, Kuo CC, Wang SP, Stewart D, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172:585-588.
16. Davidson M, Kuo CC, Middaugh JP, et al. Chlamydia pneumoniae (TWAR in Alaska natives with coronary atheroma [abstract]. Clin Infect Dis 1995; 21:726.
17. Varghese PJ, Gaydos CA, Arumugham SB, Pham DG, Quinn TC, Tuazon CU. Demonstration of Chlamydia pneumoniae in coronary atheroma specimens from young patients with normal cholesterol from the southern part of India [abstract]. Clin Infect Dis 1995; 21:728.
18. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995; 92:6911-6914.
19. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Mee MJ, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92:3397-3400.
20. Ong G, Thomas BG, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996; 49:101-106.
21. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagouni LA, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996; 27:1555-1561
22. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996, 173:957-962.
23. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae Atherosclerosis Study Group. Ann Intern Med 1996; 125:979-982.
24. Blasi F, Denti F, Erba M, Consentini R, Raccanelli R, Rinaldi R, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996; 34:2766-2769.
25. Jackson LA, Campbell LA, Kno CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumonia from a carotid atherosclerotic plaque specimen. J Infect Dis 1997; 176:292-295.
26. Juvonen J, Juvonen T, Laurila A, Alakärppa H, Lounatmaa K, Surcel H-M. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 1997; 25:499-505.
27. Juvonen J, Laurila A, Juvonen T, Alakärppa H, Surcel H-M, Lounatmaa K, et al. Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1996; 29:1054-1059.
28. Moazed TC, Kuo CC, Patton DL, Grayston JT, Campbell LA. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol 1996; 148:667-678.
29. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immunol 1996; 64:1614-1620.
30. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 1996; 21:215-221.
31. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham EW, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311:711-714.
32. Leatham EW, Bath PM, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73:10-13.
33. Fong IW, Chiu B, Viva E, Fong MW, Jang D, Mahoney J. Rabbit models for Chlamydia pneumoniae infection. J Clin Microbiol 1997; 35:48-52.
34. Laitinen K, Laurila A, Pyhälä L, Leinonen M, Saikku P. Chlamydia pneumoniae induces inflammatory changes in the aortas of rabbits. Infect Immunol 1997; 65:4832-4835.
35. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96:404-407.
36. Gurfinkel E, Bozovich G, Darcoca A, Beck E, Mautner B. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350:404-407.
37. Gupta S, Mendall MA, Leatham EW, Carrington D, Tooze JT, Ireson N, et al. Azithromycin reduces haemostatic markers, inflammation and monocyte activation in post-MI patients with elevated Chlamydia pneumoniae antibodies [abstract]. Medical Research Society Spring Meeting, London, May 1997.
38. Black PN. Anti-inflammatory effects of macrolide antibiotics. Eur Resp J 1997; 10:971-972.
39. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97:633-636.
40. Gupta S, Kaski JC, Camm AJ. Antibiotic therapy in coronary heart disease: hype versus hope. Br J Cardiol 1998; 5:65-66.